Former Director of Centre for Cellular and Molecular Biology (CCMB), Dr Rakesh Mishra, said that 2-deoxy-D-glucose (2-DG) drug would do wonders in fighting against mild and severe Covid-19 cases.
This anti Covid-19 drug developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a Defence Research and Development Organisation along with Dr Reddy’s Laboratories, with the help of CCMB has been approved by the Drug Controller General of India.